Paecilomyces Pneumonia Despite Voriconazole Prophylaxis: A Case Report and Literature Review

Abuzar A Asif1, Moni Roy1, Sharjeel Ahmad2

  • 1Department of Internal Medicine, University of Illinois College of Medicine at Peoria, OSF Saint Francis Medical Center, Peoria, USA.

Insights

Paecilomyces pneumonia is a rare fungal infection in immunocompromised individuals. Breakthrough infections can occur even with voriconazole prophylaxis, but posaconazole shows effectiveness against these Paecilomyces species.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Pulmonology

Background:

  • Paecilomyces species are uncommon causes of fungal pulmonary infections, primarily affecting immunocompromised hosts.
  • Paecilomyces variotii and Paecilomyces lilacinus are the most clinically relevant species, exhibiting differential susceptibility to antifungal medications.

Purpose of the Study:

  • To report a rare case of Paecilomyces pneumonia in an immunocompromised patient receiving voriconazole prophylaxis.
  • To review existing literature on Paecilomyces pulmonary infections in immunocompromised individuals.

Main Methods:

  • Case report of a 47-year-old immunocompromised woman with Paecilomyces pneumonia.
  • Literature review of previously reported cases of Paecilomyces pulmonary infections.

Main Results:

  • The patient developed Paecilomyces pneumonia despite prophylactic voriconazole treatment, highlighting breakthrough infections.
  • Literature review indicates varying antifungal susceptibility profiles among Paecilomyces species.

Conclusions:

  • Paecilomyces species demonstrate distinct antifungal susceptibility patterns.
  • Invasive mold infections by Paecilomyces are increasingly observed in immunocompromised patients on voriconazole prophylaxis.
  • Posaconazole has demonstrated efficacy against both Paecilomyces variotii and Paecilomyces lilacinus.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...